To further note the story, I came away with the belief that the FDA is in no hurry to allow gene manipulation via vaccine or injection due to recent failure in Stage III testing however the topical percutaneous absorption method was positvely highlighted. If cygx can stop tripping over its collective,,,,,,,,,,,,self, maybe Simplivir has a chance.